Ergotamine (Sheffield)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameErgotamine (Sheffield)
Drug Alias NameErgotamine bitartrateTempo-ergotamineErgotamine (Sheffield)ergotamineergotamine tartrate (Sheffield)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor antagonistsSerotonin 5-HT1 receptors antagonistsSerotonin 5-HT1 receptors partial agonists
TargetsSerotonin 5-HT1 receptorsAlpha adrenergic receptor
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesTheriva Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElan CorpTheriva Biologics Inc
Active IndicationsN/A
Inactive IndicationsMigraine Disorders

Other Information

ATC CodeN/A
Related LinksN/A